Home/Filings/4/0001181431-10-033915
4//SEC Filing

Gibbs Andrew 4

Accession 0001181431-10-033915

CIK 0001459450other

Filed

Jun 17, 8:00 PM ET

Accepted

Jun 18, 4:10 PM ET

Size

5.1 KB

Accession

0001181431-10-033915

Insider Transaction Report

Form 4
Period: 2010-06-16
Gibbs Andrew
Vice President, Legal
Transactions
  • Sale

    Common Stock

    2010-06-16$3.78/sh1,153$4,3597,847 total
Footnotes (1)
  • [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 31, 2010, and was made to fund certain out-of-pocket tax withholding liabilities associated with the vesting of restricted stock units granted on July 1, 2009.

Issuer

Myriad Pharmaceuticals, Inc.

CIK 0001459450

Entity typeother

Related Parties

1
  • filerCIK 0001465779

Filing Metadata

Form type
4
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 4:10 PM ET
Size
5.1 KB